http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102961336-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aee739903a8ffe4df1a67e8dd992cf44
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-501
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2012-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2014-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c142aa8363bd9d19759b7022528a4dc2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b2d440b47e2886712009611bd21b6dc1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd2d644ad34091921bb39e8f2e73fa36
publicationDate 2014-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-102961336-B
titleOfInvention Nanoscale platinum drug and preparation method thereof
abstract The invention discloses a nanoscale platinum drug and a preparation method thereof, relating to an anti-tumor platinum drug. In allusion to the defects that the platinum drugs are low in solubility and low in biological utilization rate of oral administration and the existing platinum drug injections have server toxic and side effects, the invention firstly aims at providing a novel nanoscale platinum drug particle which is characterized by taking silicon dioxide aerogel as a carrier of the platinum drug; and the invention secondly aims at providing a preparation method of the novel nanoscale platinum drug particle; and the preparation method is characterized by comprising the steps of: dissolving the platinum drug in a 1.5%(W/V) Nacl solution, adding the silicon dioxide aerogel according to proportion, drying after complete adsorption, adding purified water and sending into an emulsifying machine for emulsification, homogenizing through a high-pressure homogenizer, and drying the obtained homogenate to obtain the nanoscale platinum drug particle. The nanoscale platinum drug provided by the invention is particularly suitable for oral administration.
priorityDate 2012-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101111225-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707758
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415133005
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23939
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6857599
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458431511

Total number of triples: 28.